Molecular specific optoacoustic imaging with plasmonic nanoparticles.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Medical Imaging

Background:

• Gold nanoparticles (AuNPs) can be functionalized with antibodies for targeted molecular biomarker detection.
• Epithelial growth factor receptor (EGFR) is a key biomarker in various human epithelial cancers.
• Early cancer detection is crucial for effective treatment and improved patient outcomes.

Purpose of the Study:

• To develop and evaluate an optoacoustic imaging technique for early-stage cancer detection.
• To assess the specificity and sensitivity of antibody-functionalized gold nanoparticles targeting EGFR.
• To validate the use of anti-EGFR gold nanoconjugates in detecting human epithelial cancer cells.

Main Methods:

• Functionalization of gold nanoparticles with anti-EGFR antibodies.
• Preparation of three-dimensional tissue phantoms using a human keratinocyte cell line.
• Optoacoustic imaging using 532 nm and 680 nm pulsed laser irradiation.

Main Results:

• Demonstrated specific binding of anti-EGFR gold nanoconjugates to EGFR.
• Achieved highly sensitive and selective detection of human epithelial cancer cells.
• Validated the efficacy of the developed optoacoustic imaging method in tissue phantoms.

Conclusions:

• Optoacoustic imaging combined with anti-EGFR gold nanoconjugates offers a promising approach for early cancer detection.
• The technique allows for sensitive and selective identification of cancer cells based on molecular biomarkers.
• Further research may lead to clinical applications for asymptotic cancer diagnosis.